End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,959 KRW | -0.66% | +3.76% | -3.26% |
04-02 | NeoImmuneTech, Inc. Announces Chief Executive Officer Changes | CI |
01-15 | NeoImmuneTech, Inc. Appoints Luke Oh as President | CI |
Business Summary
Number of employees: 100
Managers
Managers | Title | Age | Since |
---|---|---|---|
Se-Hwan Yang
FOU | Founder | 54 | 13-12-31 |
Tae-Woo Kim
DFI | Director of Finance/CFO | 44 | 18-04-30 |
Dana Wyche
CTO | Chief Tech/Sci/R&D Officer | - | - |
Donghoon Choi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Byung-ha Lee
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jean Fan
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Gene Namgoong
COO | Chief Operating Officer | - | 15-12-31 |
Hayoung Lee
IRC | Investor Relations Contact | - | - |
Daniel Rho
PRN | Corporate Officer/Principal | - | - |
Jin-Hee Kang
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Se-Hwan Yang
FOU | Founder | 54 | 13-12-31 |
Soo-Hyoung Kang
BRD | Director/Board Member | - | - |
Jung-Won Woo
BRD | Director/Board Member | 64 | - |
Tae-Woo Kim
DFI | Director of Finance/CFO | 44 | 18-04-30 |
Byoung-Jo Kang
BRD | Director/Board Member | 49 | - |
Jin-Hyoung Kang
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 19,773,493 | 0 | 0 | - |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-3.26% | 28.76M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- A950220 Stock
- Company NeoImmuneTech, Inc.